PCSK9 Inhibitors: Heralding A New Era In Dyslipidemia Management
Journal Title: BMH Medical Journal - Year 2019, Vol 6, Issue 4
Abstract
Dyslipidemia is a well known risk factor for cardiovascular disease. Till now statins were the sheet anchor of therapy for dyslipidemia. But there are a few patients who are intolerant to statins and some who develop cardiovascular disease in spite of maximally tolerated dose of statins. Still there are some others like those with familial hypercholesterolemia who do not achieve adequate reduction of cholesterol levels with statins alone or in combination with ezetimibe. Now we have a new group of medications - proprotein convertase subtilsin-kexin type 9 (PCSK9) inhibitors, to cater to these group of patients.
Authors and Affiliations
Johnson Francis
Keywords
Related Articles
- EP ID EP648141
- DOI -
- Views 117
- Downloads 0
Early Repolarization Syndrome
The electrocardiographic pattern of early repolarization (ER) is common, with a particularly high prevalence reported amongst athletes and adolescents. It has long been associated with benign outcome. Recently, an associ...
Paediatric Ambulatory Surgery
The International Association for Ambulatory Surgery (IAAS) defined Ambulatory surgery in 1995 as a ‟surgical or diagnostic interventions, currently performed with traditional hospitalisation, that could, in most cases,...
Outbreak of Enterovirus - 71 Meningitis in Calicut
Objective: Enterovirus 71(EV 71) causes wide spectrum of infections ranging from asymptomatic conditions to clinical syndromes like diarrhea, rash, hand-foot-and mouth disease (HFMD), herpangina, aseptic meningitis, enc...
Atypical Presentation of Epithelial Ovarian Carcinoma as Isolated Hepatic Metastases From Unknown Primary
Epithelial ovarian carcinoma usually presents in very advanced stages with extensive intraabdominal disease in the form of omental and peritoneal deposits and gross ascites. Liver surface deposits are fairly common with...
Current Thinking In Pediatric Peri-operative Fluid Therapy
Proper perioperative fluid management is critical to maintain cardiovascular stability and adequate tissue perfusion. The volume and composition of fluid should be adapting to the physiology of the child and compensating...